Inventor · disambiguated record
Richard C. Duke
Also filed as: DUKE RICHARD C
17 granted patents·3 pending applications·644 citations·filing 1994–2013
95Inventor score
Top patents by PatentIndex Score
20 records- 0198US7439042B2Yeast-based therapeutic for chronic hepatitis C infectionGLOBEIMMUNE INC·Filed 2005·Granted Oct 21, 2008·72 cites·42 claims
- 0297US7595060B2Yeast-antigen compositions methods of making the sameGLOBEIMMUNE INC·Filed 2006·Granted Sep 29, 2009·53 cites·19 claims
- 0397US7083787B2Yeast-dendritic cell vaccines and uses thereofUNIV COLORADO·Filed 2001·Granted Aug 1, 2006·113 cites·17 claims
- 0496US7632511B2Yeast-based therapeutic for chronic hepatitis C infectionGLOBEIMMUNE INC·Filed 2006·Granted Dec 15, 2009·37 cites·43 claims
- 0596US7625569B2Yeast-based therapeutic for chronic hepatitis C infectionGLOBEIMMUNE INC·Filed 2006·Granted Dec 1, 2009·39 cites·27 claims
- 0696US5830463AYeast-based delivery vehiclesUNIV TECHNOLOGY CORP·Filed 1994·Granted Nov 3, 1998·189 cites·12 claims
- 0795US7736642B2Yeast-based vaccine for inducing an immune responseGLOBEIMMUNE INC·Filed 2007·Granted Jun 15, 2010·46 cites·23 claims
- 0894US8007816B2Yeast-based therapeutic for chronic hepatitis C infectionGLOBEIMMUNE INC·Filed 2008·Granted Aug 30, 2011·21 cites·12 claims
- 0991US8221763B2Yeast-antigen compositions and methods of using the sameDUKE RICHARD C·Filed 2009·Granted Jul 17, 2012·9 cites·24 claims
- 1090US8388980B2Yeast-based therapeutic for chronic hepatitis C infectionDUKE RICHARD C·Filed 2009·Granted Mar 5, 2013·15 cites·17 claims
- 1183US8821892B2Yeast-based therapeutic for chronic hepatitis C infectionGLOBEIMMUNE INC·Filed 2013·Granted Sep 2, 2014·4 cites·20 claims
- 1275US8728489B2Immunotherapy for chronic hepatitis C virus infectionAPELIAN DAVID·Filed 2009·Granted May 20, 2014·2 cites·19 claims
- 1371US8715645B2Viral vectors encoding apoptosis-inducing proteins and methods for making and using the sameBELLGRAU DONALD·Filed 2004·Granted May 6, 2014·4 cites·3 claims
- 1468US5759536AUse of fas ligand to supress T-lymphocyte-mediated immune responsesUNIV TECHNOLOGY CORP·Filed 1995·Granted Jun 2, 1998·21 cites·7 claims
- 1567US6325999B1Use of Fas ligand to suppress T-lymphocyte-mediated immune responsesUNIV TECHNOLOGY CORP·Filed 1998·Granted Dec 4, 2001·19 cites·8 claims
- 1662US2013052220A1Yeast-hiv antigen compositions and methods of using the sameDUKE RICHARD C·Filed 2012·Application pending·0 cites
- 1745US9216206B2Methods of treating symptoms associated with menopause and hormonal variations with G-CSFDUKE DEBRA M·Filed 2009·Granted Dec 22, 2015·0 cites·20 claims
- 1840US10352936B2Use of tumor Fas expression to determine response to anti-cancer therapyMODIANO JAIME·Filed 2012·Granted Jul 16, 2019·0 cites·4 claims
- 1940US2010196411A1Yeast-Based Vaccine for Inducing an Immune ResponseGLOBELMMUNE INC·Filed 2010·Application pending·0 cites
- 2033US2012220753A1N-Terminal Dimerization Methods with Bis-Amindino Acid and Bis-Thioimidate DerivativesGERA LAJOS·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →